Statistics for Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya: Results from the SABINA III Study
Total visits
| views | |
|---|---|
| Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya: Results from the SABINA III Study | 1 |
Total visits per month
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
File Visits
| views | |
|---|---|
| Over-Prescription of Short-Acting β2-Agonists Remains a Serious Health Concern in Kenya....pdf | 40 |